Streetbeat News

SCM

Stellus Capital Investment Corporation

https://www.stelluscapital.com/public-investors/investment-corp/

Industry

Asset Management

Stellus Capital Investment Corporation is a business development company specializing in investments in private middle-market companies. It invests through first lien, second lien, unitranche, and mezzanine debt financing, often with a corresponding equity investment. The fund prefers to invest in US and Canada. The fund seeks to invest in companies with an EBITDA between $5 million and $50 million.

Open

13.93

Mkt cap

373M

Volume

145K

High

13.95

P/E Ratio

6.90

52-wk high

14.68

Low

13.73

Div yield

0.12

52-wk low

12.48

Stellus Cap Investment (NYSE:SCM) is scheduled to release its quarterly earnings report on March 4, 2024, with analysts expecting an EPS of $0.45. The company's past earnings performance shows a pattern of beating EPS estimates but experiencing a subsequent drop in share price. Over the last year, SCM shares have declined by 16.93%, indicating a bearish outlook among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 4:00 pm

Three financial stocks, FS KKR Capital Corp. (FSK), Lazard, Inc. (LAZ), and Stellus Capital Investment Corporation (SCM), are considered overbought based on their RSI values, which are above the threshold of 70. FSK's RSI is at 73.57 after a recent public offering and a price increase. LAZ's RSI is at 78.45 following an announcement of preliminary assets under management and a stock gain. SCM's RSI is at 71.32 after a downgrade by an analyst and a modest price increase.

Portfolio Pulse from Avi Kapoor

January 19, 2024 | 1:29 pm

B. Riley Securities analyst Bryce Rowe has downgraded Stellus Capital Investment (NYSE:SCM) from Neutral to Sell and set a price target of $13.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:25 pm

Stellus Cap Investment (NYSE:SCM) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $0.47. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $13.29, down 5.61% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 9:02 pm

B. Riley Securities analyst Bryce Rowe has maintained a Neutral rating on Stellus Cap Investment (NYSE:SCM) and raised the price target from $14 to $14.25.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 1:12 pm

Oppenheimer analyst Mitchel Penn has downgraded Stellus Cap Investment (NYSE:SCM) from Outperform to Perform and set a price target of $15.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 10:54 am

Stellus Cap Investment (NYSE:SCM) reported Q2 earnings of $0.51 per share, beating the analyst consensus estimate of $0.47 by 8.51%. This is a 75.86% increase from the same period last year. The company also reported quarterly sales of $26.59 million, beating the analyst consensus estimate of $25.50 million by 4.25%, a 65.03% increase from the same period last year.

Portfolio Pulse from vinayak@benzinga.com

August 09, 2023 | 9:03 pm

Benzinga has released its top ratings upgrades and downgrades for June 16, 2023. Notable upgrades include West Pharmaceutical Services, Abcam, AutoZone, and MorphoSys, while downgrades include Applied Materials, Truist Financial, Bausch Health Companies, RPC, NexTier Oilfield Solutions, Evotec, and SoFi Technologies.

Portfolio Pulse from Benzinga Insights

June 16, 2023 | 3:01 pm

B. Riley Securities analyst Bryce Rowe initiates coverage on Stellus Cap Investment (NYSE:SCM) with a Neutral rating and announces a price target of $14.

Portfolio Pulse from richadhand@benzinga.com

June 16, 2023 | 8:40 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.